Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, C. Allison Stewart et al.|Cancer Cell|2021Cited by 930
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancerSarah M. Groves, Vito Quaranta, Perry T. Wasdin et al.|Cell Systems|2022Cited by 59
Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLCPortia Thomas, Christine M. Lovly, Sarah M. Groves et al.|Journal of Thoracic Oncology|2021Cited by 33